At the 2018 National Rx Drug Abuse and Heroin Summit physicians, researchers and leaders from UK and UK HealthCare joined experts from across the nation to discuss how they are combating the opioid epidemic in the Commonwealth.
Last week, the UK Office of Technology Commercialization held its second annual Patent Palooza, an event that celebrates the university's inventors and commercialization deals of the previous fiscal year.
New findings from University of Kentucky researchers published in Nature Chemical Biology help reveal how nature makes complex chemicals with anticancer properties.
Sixteen UK undergraduate researchers presented their research at the 17th annual Posters-at-the-Capitol in Frankfort on Feb. 8. Each had a chance to share their research with UK President Eli Capilouto as well as several state legislators.
In its ongoing efforts to offer Kentuckians the latest, most innovative cancer treatments available, the UK Markey Cancer Center recently launched the Precision Medicine Clinic, a new space dedicated to providing patients with increased access to phase I and phase II clinical trials.
With UK researchers on the forefront of fighting the opioid crisis, their message to members of the U.S. House of Representatives and Senate emphasized the need for continued federal funding of research addressing drug addiction and abuse.
New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.
Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.
